Spanish Society for Gene and Cell Therapy

The objective of the SETGyC is to:

  • boost the profile of gene and cell therapy in Spain and the international community;
  • facilitate communication and exchange of expertise and resources between professionals;
  • provide advice and advocacy in all themes relating to new and existing gene and cell therapies.

Gene therapy as well as cell therapy are part of biomedicine, and are more and more inter-related.  They could revolutionise the treatment of several pathologies most of which do not have any alternative therapy at the moment.

It is an ever evolving field which requires collaboration of experts in many different areas of biology, engineering, medicine etc.  The enormous potential of this strategy has raised the expectations of society but also comes with some misgivings when it comes to ethics and safety.

Through its activities, the SETGyC hopes to support basic and translational research aimed at the advancement of gene and cell therapy in our country by promoting the incorporation of the latest international developments in the field.

The SETGyC aims to provide a link between researchers, health professionals, regulators and Spanish society to better understand the current state of knowledge and application of gene and cell therapy.

News

President's Letter

Juan Bueren 132The Spanish Society of Gene and Cell Therapy ( SETGyC ) is a platform that aims to promote and support basic, translational and clinical research in these areas, as well as cooperation with institutions, biotechnological and pharmaceutical companies for development of new therapies. Continue the letter